E. Schnürer

Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.

S. Strand, E. Ranieri, C. Huber, 2006, Cancer research.

Patient‐individualized CD8+ cytolytic T‐cell therapy effectively combats minimal residual leukemia in immunodeficient mice

Shamsul A. Khan, A. Mottok, A. Beilhack, 2016, International journal of cancer.

Varicella-zoster virus glycoproteins B and E are major targets of CD4+ and CD8+ T cells reconstituting during zoster after allogeneic transplantation

S. Tenzer, H. Schild, B. Plachter, 2012, Haematologica.

The Programmed Death (PD)‐1/PD‐Ligand 1 Pathway Regulates Graft‐Versus‐Host‐Reactive CD8 T Cells After Liver Transplantation

G. Otto, C. Huber, E. von Stebut, 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Acute myeloid leukemia (AML)-reactive cytotoxic T lymphocyte clones rapidly expanded from CD8(+) CD62L((high)+) T cells of healthy donors prevent AML engraftment in NOD/SCID IL2Rgamma(null) mice.

C. Huber, T. Wölfel, R. Meyer, 2008, Experimental hematology.

CD8+ cytotoxic T lymphocytes isolated from allogeneic healthy donors recognize HLA class Ia/Ib-associated renal carcinoma antigens with ubiquitous or restricted tissue expression.

L. Gesualdo, C. Albrecht, M. Karas, 2004, Blood.

The T-box transcription factor eomesodermin controls CD8 T cell activity and lymph node metastasis in human colorectal cancer

M. Neurath, P. Galle, S. Wirtz, 2007, Gut.

Proteasome-inhibited dendritic cells demonstrate improved presentation of exogenous synthetic and natural HLA-class I peptide epitopes.

C. Huber, T. Tüting, T. Wölfel, 2006, Journal of immunological methods.

Alloreactive and leukemia-reactive T cells are preferentially derived from naïve precursors in healthy donors: implications for immunotherapy with memory T cells

M. Theobald, Alexander Hohberger, W. Herr, 2011, Haematologica.

Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation.

C. Huber, B. Plachter, R. Meyer, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

In Vitro Stimulation and Expansion of Human Tumour‐Reactive CD8+ Cytotoxic T Lymphocytes by Anti‐CD3/CD28/CD137 Magnetic Beads

M. Theobald, W. Herr, D. Teschner, 2011, Scandinavian journal of immunology.